Dr. Emilio Ros was the creator and head until 2016 of the Lipid Unit, Endocrinology and Nutrition Service, Hospital Clínic, Barcelona. He is currently an Emeritus Researcher at the August Pi Sunyer Biomedical Research Institute (IDIBAPS), Barcelona. Former principal investigator and currently member of the CIBEROBN Group, Instituto de Salud Carlos III, Madrid.

His postgraduate training took place in the USA, 1970-1976 (New York and Boston), where he obtained the American Board of Internal Medicine and the American Board of Gastroenterology. He was a founding member of the Spanish Society of Arteriosclerosis (SEA) and founder and editor of its official journal Clínica e Investigación en Arteriosclerosis. He is a member of the European Atherosclerosis Society (EAS), International Atherosclerosis Society (IAS), American Society of Nutrition, and American College of Cardiology. He was president of the Ibero-Latin American Society of Atherosclerosis (SILAT) from 2000 to 2005.

Dr. Emilio Ros’ scientific contribution to the fields of nutrition, lipidology, and atherosclerosis has been recognized by being considered as part of the 1% of most cited and influential scientists in the world by Clarivate Analytics 2018-2021. He has published in journals with FI: 530 originals, 95 reviews and 30 editorials, as well as 90 book chapters (Google Scholar h-index: 113; ORCID identifier 0000-0002-2573-1294). In recognition of his scientific career, he has received the awards for the best scientific career in nutrition from the Danone Foundation 2013, SEA 2014 and the Catalan Nutrition Centre 2015. Dr. Emilio Ros was responsible for the nutritional intervention in the pioneering PREDIMED clinical study of the Mediterranean Diet for primary cardiovascular prevention.